At a glance
ClinicalIndex Comparison RecordN/AUnknown· 150 target
Drug / intervention
PURE EP (Observational Study)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
To Assess the Predictive Value of High Frequency Algorithm of PURE EP for Low Amplitude Signal Detection
In Brief
An observational study evaluating PURE EP (Observational Study) for Cardiac Arrhythmias. Targeting 150 participants across 1 site.
Detailed Summary
Prior multicenter study demonstrated superiority of PURE EP to conventional mapping. This superiority was seen when comparing small, fractionated signals of interest, near-field vs far-field distinction, and general signal quality (2). Hence, investigators propose a retrospective study to assess the predictive value of high frequency algorithm (HFA) for identifying local physiologic signal under 0.3 mV distinctive of noise.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrhythmias
CountriesUnited States
Collaborators--
Timeline
N/AUnknownOverdue
2023202420252026
First PostedJul 2022
Enrollment StartApr 2023
Primary CompletionOct 2023
Study CompletionDec 2023
TodayJul 2026
First PostedJul 8, 2022
Enrollment StartApr 1, 2023
Primary CompletionOct 1, 2023
Study CompletionDec 1, 2023
TodayJul 1, 2026
Enrollment to primary: 6 monthsPosted 4.0 years ago
Interventions
PURE EP (Observational Study)other
This is an observational study. No interventions involved in this study.